An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users

Journal of Infectious Diseases

Volumn 174, Issue 2, 1996, Pages 309-317

  Hershow, Ronald C ^a   Galai, Noya ^b   Fukuda, Keiji ^c   Graber, Judith ^c   Vlahov, David ^c   Rezza, Giovanni ^c   Klein, Robert S ^c   Des Jarlais, Don C ^c   Vitek, Chuck ^c   Khabbaz, Rima ^c   Freels, Sally ^c   Zuckerman, Richard ^c   Pezzotti, Patrizio ^c   Kaplan, Jonathan E ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; DRUG USE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOBLOTTING; INTERNATIONAL COOPERATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION;

EID: 19144372121     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.2.309     Document Type: Article

References (13)

1. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
2. Hjelle B. Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med 1991;115:440-50.
3. Kaplan JE, Khabbaz RF. The epidemiology of human T-lymphotropic virus types I and II. Rev Med Virol 1993;3:137-48.
4. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS. High rate of HTLV-II infection in seropositive iv drug abusers in New Orleans. Science 1989;244:471-5.
5. Centers for Disease Control and Prevention. HTLV-I screening in volunteer blood donors - United States, 1989. MMWR Morb Mortal Wkly Rep 1990;39:915-24.
6. Kleinman S, Fitzpatrick L, Lee H. Transmission of HTLV-I/II from blood donors to their sexual partners [abstract]. In: Program and abstracts: International Society of Blood Transfusion/American Association of Blood Banks Joint Congress Meeting (Los Angeles). Arlington, VA: American Association of Blood Banks, 1990:129.
7. Vitek CR, Gracia FI, Giusti R, et al. Evidence for sexual and mother-to-child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama. J Infect Dis 1995;171:1022-6.
8. Weiss SH. The evolving epidemiology of human T lymphotropic virus type II. J Infect Dis 1994;169:1080-3.
9. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
10. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-6.
11. Harrington WJ, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-4.
12. Murphy EL, Engstrom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG. HTLV-II associated myelopathy in a 43 year old woman. Lancet 1993;341:757-8.
13. Sheremata WA, Harrington WJ, Bradshaw PA, et al. Association of "(tropical) ataxic neuropathy" with HTLV-II. Virus Res 1993;29:71-7.